ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GILD Gilead Sciences Inc

73.52
0.51 (0.70%)
Last Updated: 13:20:05
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,976,681
Bid Price 73.51
Ask Price 73.52
News (3)
Day High 73.78

Low
71.37

52 Week Range

High
87.865

Day Low 73.24
Share Name Share Symbol Market Stock Type
Gilead Sciences Inc GILD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.51 0.70% 73.52 13:20:05
Open Price Low Price High Price Close Price Previous Close
73.25 73.24 73.78 73.01
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
34,493 2,976,681 US$ 73.44 US$ 218,602,675 - 71.37 - 87.865
Last Trade Type Quantity Price Currency
13:20:05 5 US$ 73.52 USD

Gilead Sciences (GILD) Options Flow Summary

Overall Flow

Bullish

Net Premium

1M

Calls / Puts

100.00%

Buys / Sells

75.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Gilead Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
91.63B 1.25B - 27.12B 5.67B 4.55 16.17
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Gilead Sciences News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No GILD Message Board. Create One! See More Posts on GILD Message Board See More Message Board Posts

Historical GILD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week73.9074.27772.1172.756,445,349-0.38-0.51%
1 Month72.7276.2171.9273.557,512,0200.801.10%
3 Months83.7987.86571.3776.577,622,819-10.27-12.26%
6 Months75.7987.86571.3777.356,826,190-2.27-3.00%
1 Year79.9687.86571.3777.876,151,672-6.44-8.05%
3 Years65.0089.7457.16571.547,096,5608.5213.11%
5 Years63.9289.7456.5670.318,295,7339.6015.02%

Gilead Sciences Description

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition and pending Forty-Seven acquisition boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Your Recent History

Delayed Upgrade Clock